NCT02904798View on ClinicalTrials.gov

The Effects of Visible Light on the Skin After Administration of Oral Polypodium Leucotomos

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

February 14, 2017

Study Completion Date

April 23, 2017

Conditions
Photodermatoses
Interventions
DRUG

Polypodium Leucotomos

\- PL 240mg to be taken by the patient for 28 days prior to irradiation with visible light

Trial Locations (1)

48202

Henry Ford Hospital, Detroit

All Listed Sponsors
lead

Henry Ford Health System

OTHER

NCT02904798 - The Effects of Visible Light on the Skin After Administration of Oral Polypodium Leucotomos | Biotech Hunter | Biotech Hunter